S218: CORRELATION BETWEEN PROGRESSION-FREE AND OVERALL SURVIVAL IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: A COMPREHENSIVE ANALYSIS OF INDIVIDUAL PATIENT DATA FROM RANDOMIZED GHSG TRIALS

• Paul Bröckelmann,
• Horst Müller,
• Sarah Gillessen,
• Anne Sophie Jacob,
• Jesko Momotow,
• Carla Damaschin,
• Justin Ferdinandus,
• Xiaoqin Yang,
• Michael Fuchs,
• Carsten Kobe,
• Hans T. Eich,
• Andreas Engert,
• Peter Borchmann,
• Bastian von Tresckow

Affiliations

Paul Bröckelmann

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Horst Müller

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Sarah Gillessen

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Anne Sophie Jacob

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Jesko Momotow

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Carla Damaschin

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Justin Ferdinandus

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Xiaoqin Yang

2 Merck & Co., Kenilworth, United States

Michael Fuchs

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Carsten Kobe

3 University Hospital of Cologne, Department of Nuclear Medicine, Cologne, Germany

Hans T. Eich

4 University Hospital of Muenster, Department of Radiation Oncology, Muenster, Germany

Andreas Engert

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Peter Borchmann

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany

Bastian von Tresckow

1 University Hospital Cologne, Department I of Internal Medicine and German Hodgkin Study Group (GHSG), Cologne, Germany